T2 Biosystems TTOO
$ 0.79
-0.66%
Quarterly report 2024-Q2
added 08-08-2024
T2 Biosystems Balance Sheet 2011-2024 | TTOO
Annual Balance Sheet T2 Biosystems
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-7.48 M | -763 K | -11.7 M | 73.7 M | 35.7 M | -7.67 M | -95 K | -32.7 M | -43 M | -52.9 M | -25.1 M | -3.83 M | - |
Long Term Debt |
6.6 M | 8.21 M | 9.36 M | 45.2 M | - | - | 1.01 M | 39.5 M | 26.2 M | 20.7 M | 3.3 M | 5.06 M | - |
Long Term Debt Current |
1.62 M | 1.35 M | 1.17 M | 1.15 M | 1.98 M | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | 60.6 M | 1.92 M | 625 K | 1.74 M | 40.3 M | 27.7 M | 21 M | 117 M | 72 M | - |
Total Current Liabilities |
56.2 M | 10.1 M | 11.7 M | 9.8 M | 60.6 M | 52.3 M | 51.8 M | 9.88 M | 12.3 M | 5.17 M | - | - | - |
Total Liabilities |
62.8 M | 74 M | 73.4 M | 70.4 M | 62.5 M | 52.9 M | 53.5 M | 50.2 M | 40 M | 26.1 M | 121 M | 74.1 M | - |
Deferred Revenue |
224 K | 172 K | 518 K | 230 K | 285 K | 697 K | 1.74 M | 2.44 M | 2.15 M | 80 K | - | - | - |
Retained Earnings |
-584 M | -534 M | -472 M | -423 M | -376 M | -317 M | -266 M | -204 M | -149 M | -104 M | -89.5 M | -62.7 M | - |
Total Assets |
34.8 M | 34.3 M | 60.5 M | 79.1 M | 28.5 M | 64.3 M | 54.9 M | 89.6 M | 86.9 M | 79.1 M | 31.9 M | 11.4 M | - |
Cash and Cash Equivalents |
15.7 M | 10.3 M | 22.2 M | 16.8 M | 11 M | 50.8 M | 41.8 M | 73.5 M | 73.7 M | 73.8 M | 30.2 M | 9.71 M | - |
Book Value |
-28 M | -39.7 M | -12.9 M | 8.73 M | -34 M | 11.4 M | 1.34 M | 39.3 M | 46.9 M | 53 M | -89.5 M | -62.7 M | - |
Total Shareholders Equity |
-28 M | -39.7 M | -12.9 M | 8.73 M | -34 M | 11.4 M | 1.34 M | 39.3 M | 46.9 M | 53 M | -89.5 M | -62.7 M | - |
All numbers in USD currency
Quarterly Balance Sheet T2 Biosystems
2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
5.75 M | 6.18 M | 6.6 M | 7.43 M | 7.83 M | 8.21 M | 8.57 M | 8.75 M | 9.06 M | 9.36 M | 9.66 M | 9.96 M | 10.3 M | 10.5 M | 10.5 M | 10.5 M | 10.5 M | 1.87 M | 1.87 M | 1.87 M | 1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
27.6 M | 62.5 M | 62.8 M | 73.6 M | 82.6 M | 74 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
237 K | 185 K | 224 K | 265 K | 149 K | 172 K | 163 K | 142 K | 338 K | 518 K | 613 K | 438 K | 400 K | 230 K | 230 K | 230 K | 230 K | 285 K | 285 K | 285 K | 285 K | 697 K | 697 K | 925 K | 887 K | 1.74 M | 2.08 M | 2.49 M | 1.74 M | 2.44 M | 2.44 M | 2.44 M | 2.44 M | 2.15 M | 2.15 M | 2.15 M | 2.15 M | 80 K | 80 K | 80 K | 80 K | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
-607 M | -598 M | -584 M | -559 M | -552 M | -534 M | -524 M | -507 M | -489 M | -472 M | -460 M | -446 M | -434 M | -423 M | -423 M | -423 M | -423 M | -376 M | -376 M | -376 M | -376 M | -317 M | -317 M | -317 M | -317 M | -266 M | -266 M | -266 M | -266 M | -204 M | -204 M | -204 M | -204 M | -149 M | -149 M | -149 M | -149 M | -104 M | -104 M | -104 M | -104 M | -89.5 M | - | - | - | - | - | - | - | - | - | - | - |
Total Assets |
21.7 M | 24.8 M | 34.8 M | 37.1 M | 32.7 M | 34.3 M | 44 M | 39.6 M | 49 M | 60.5 M | 70 M | 78.9 M | 70.1 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 89.6 M | 89.6 M | 89.6 M | 89.6 M | 86.8 M | 86.8 M | 86.8 M | 86.8 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 31.9 M | 31.9 M | 31.9 M | - | - | - | - | - | - | - | - | - |
Cash and Cash Equivalents |
4.25 M | 6.21 M | 15.7 M | 16.1 M | 10.1 M | 10.3 M | 20.4 M | 13.2 M | 9.4 M | 22.2 M | 22 M | 32.7 M | 10.7 M | 16.8 M | 16.8 M | 16.8 M | 16.8 M | 11 M | 11 M | 11 M | 11 M | 50.8 M | 50.8 M | 50.8 M | 50.8 M | 41.8 M | 41.8 M | 41.8 M | 41.8 M | 73.5 M | 73.5 M | 73.5 M | 73.5 M | 73.7 M | 73.7 M | 73.7 M | 73.7 M | 73.8 M | 73.8 M | 73.8 M | 73.8 M | 30.2 M | 30.2 M | 30.2 M | - | 9.71 M | - | - | - | 18.7 M | - | - | - |
Book Value |
-5.9 M | -37.8 M | -28 M | -36.4 M | -49.9 M | -39.7 M | 44 M | 39.6 M | 49 M | 60.5 M | 70 M | 78.9 M | 70.1 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 28.5 M | 28.5 M | 28.5 M | 28.5 M | 64.3 M | 64.3 M | 64.3 M | 64.3 M | 54.9 M | 54.9 M | 54.9 M | 54.9 M | 89.6 M | 89.6 M | 89.6 M | 89.6 M | 86.8 M | 86.8 M | 86.8 M | 86.8 M | 79.1 M | 79.1 M | 79.1 M | 79.1 M | 31.9 M | 31.9 M | 31.9 M | - | - | - | - | - | - | - | - | - |
Total Shareholders Equity |
-5.9 M | -37.8 M | -28 M | -36.4 M | -49.9 M | -39.7 M | -31.7 M | -37.5 M | -25.7 M | -12.9 M | -2.46 M | 9.01 M | -566 K | 8.73 M | 8.73 M | 8.73 M | 8.73 M | -34 M | -34 M | -34 M | -34 M | 11.4 M | 11.4 M | 11.4 M | 11.4 M | 1.34 M | 1.34 M | 1.34 M | 1.34 M | 39.3 M | 39.3 M | 39.3 M | 39.3 M | 46.9 M | 46.9 M | 46.9 M | 46.9 M | 53 M | 53 M | 53 M | 53 M | -89.5 M | -89.5 M | -89.5 M | - | -62.7 M | - | - | - | -44.2 M | - | - | - |
All numbers in USD currency